ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
Read More
Safety-net clinics nationwide expanded heat action plans this summer to protect vulnerable populations from extreme heat-related health risks.
Read More
The AMA introduced a policy framework to prevent AI deepfake impersonations of physicians and protect patient safety.
Read More
Erasca’s experimental pan-RAS pill shrank tumors in 40% of advanced pancreatic and 62% of non-small cell lung cancer patients in trials.
Read More
The AMA secured key provisions in CMS’s 2027 Medicare Advantage final rule, including a 2.48% payment increase and updated Star Ratings.
Read More
The Pennsylvania House Health Committee voted on HB 916 to update childhood blood lead testing requirements statewide.
Read More
Over 2,500 physicians and addiction experts gathered in Atlanta for the 13th annual Rx and Illicit Drug Summit to address the opioid crisis.
Read More
The FDA and CMS launched the RAPID pathway to speed Medicare coverage decisions for breakthrough medical devices through aligned reviews.
Read More
Breast cancer cases in U.S. women under 50 increased 1.4% annually from 2012-2022, driven by aggressive tumors and advanced-stage diagnoses.
Read More
CMS finalized the 2027 Medicare Advantage rule, enhancing quality and access but reducing plan accountability by removing some performance metrics.
Read More
